OBJECTIVES: To compare patient preferences for end-of-life care with care received at the end of life. DESIGN: A randomized controlled trial was conducted with individuals with congestive heart failure or end-stage renal disease and their surrogates who were randomized to receivepatient-centered advance care planning (PC-ACP) or usual care. SETTING:Two centers in Wisconsin with associated clinics and dialysis units. PARTICIPANTS: Of the 313 individuals and their surrogates who completed entry data, 110 died. INTERVENTION: During PC-ACP, the trained facilitator assessed individual and surrogate understanding of and experiences with the illness, provided information about disease-specific treatment options and their benefits and burden, assisted in documentation of treatment preferences, and assisted the surrogates in understanding the patient's preferences and the surrogate's role. MEASUREMENTS: Preferences were documented and compared with care received at the end of life according to surrogate interviews or medical charts. RESULTS: Patients (74%) frequently continued to make their own decisions about care to the end. The experimental group had fewer (1/62) cases in which patients' wishes about cardiopulmonary resuscitation were not met than in the control group (6/48) but not significantly so. Significantly more experimental patients withdrew from dialysis than controls. CONCLUSION: Patients and their surrogates were generally willing to discuss preferences with a trained facilitator. Most patients received the care they desired at end of life or altered their preferences to be in accord with the care they could receive. A larger sample with surrogate decision-makers is needed to detect significant differences.
RCT Entities:
OBJECTIVES: To compare patient preferences for end-of-life care with care received at the end of life. DESIGN: A randomized controlled trial was conducted with individuals with congestive heart failure or end-stage renal disease and their surrogates who were randomized to receive patient-centered advance care planning (PC-ACP) or usual care. SETTING: Two centers in Wisconsin with associated clinics and dialysis units. PARTICIPANTS: Of the 313 individuals and their surrogates who completed entry data, 110 died. INTERVENTION: During PC-ACP, the trained facilitator assessed individual and surrogate understanding of and experiences with the illness, provided information about disease-specific treatment options and their benefits and burden, assisted in documentation of treatment preferences, and assisted the surrogates in understanding the patient's preferences and the surrogate's role. MEASUREMENTS: Preferences were documented and compared with care received at the end of life according to surrogate interviews or medical charts. RESULTS:Patients (74%) frequently continued to make their own decisions about care to the end. The experimental group had fewer (1/62) cases in which patients' wishes about cardiopulmonary resuscitation were not met than in the control group (6/48) but not significantly so. Significantly more experimental patients withdrew from dialysis than controls. CONCLUSION:Patients and their surrogates were generally willing to discuss preferences with a trained facilitator. Most patients received the care they desired at end of life or altered their preferences to be in accord with the care they could receive. A larger sample with surrogate decision-makers is needed to detect significant differences.
Authors: Terri R Fried; Amy L Byers; William T Gallo; Peter H Van Ness; Virginia R Towle; John R O'Leary; Joel A Dubin Journal: Arch Intern Med Date: 2006-04-24
Authors: J Lynn; H R Arkes; M Stevens; F Cohn; B Koenig; E Fox; N V Dawson; R S Phillips; M B Hamel; J Tsevat Journal: J Am Geriatr Soc Date: 2000-05 Impact factor: 5.562
Authors: JoAnne Alissi Cosgriff; Margaret Pisani; Elizabeth H Bradley; John R O'Leary; Terri R Fried Journal: J Gen Intern Med Date: 2007-09-14 Impact factor: 5.128
Authors: Gabrielle B Rocque; J Nicholas Dionne-Odom; Chao-Hui Sylvia Huang; Soumya J Niranjan; Courtney P Williams; Bradford E Jackson; Karina I Halilova; Kelly M Kenzik; Kerri S Bevis; Audrey S Wallace; Nedra Lisovicz; Richard A Taylor; Maria Pisu; Edward E Partridge; Thomas W Butler; Linda A Briggs; Elizabeth A Kvale Journal: J Pain Symptom Manage Date: 2017-01-03 Impact factor: 3.612
Authors: Lynn F Reinke; Laura C Feemster; Jennifer McDowell; Eric Gunnink; Erica V Tartaglione; Edmunds Udris; J Randall Curtis; David H Au Journal: Heart Lung Date: 2017 Jan - Feb Impact factor: 2.210
Authors: Mi-Kyung Song; Sandra E Ward; Jason P Fine; Laura C Hanson; Feng-Chang Lin; Gerald A Hladik; Jill B Hamilton; Jessica C Bridgman Journal: Am J Kidney Dis Date: 2015-06-30 Impact factor: 8.860
Authors: Ann M O'Hare; Jackie Szarka; Lynne V McFarland; Janelle S Taylor; Rebecca L Sudore; Ranak Trivedi; Lynn F Reinke; Elizabeth K Vig Journal: Clin J Am Soc Nephrol Date: 2016-04-15 Impact factor: 8.237